This is the 51.8% subsidiary of the Merck Germany, having Book value of 334 and equity capital of just 16.6%. The co. has nil debt including short term or long term. The co. has posted good Q1- March-15 result which is sales 189.71 against 187.15 and net profit 9.62 against 3.56 of previous qurtarer. Co. has taken major step for upgrading plant and marketing strategy which can boost its presence in the market and deliver good top line and bottom line. The stock is looking good @ 865-862 for the medium to long term. You can place stop loss below 850.
what is the target and duration
ReplyDeleteDear , For good quality stock, there should not be a target or no one can set target. I would you give example, I bought Ajanta Pharma @ 200 and set target for 500, and i did and sold @ 500, but then after it increased and increased and increasing now, still i cant find target, and my target was so deceiver. However this stock can touch 4 digit in 4 to 6 month. Thanks
ReplyDelete